SCL Lifesciences is an API manufacturer based in India. It holds 22 active US drug master files across a filed portfolio of 11 molecules. Its GMP standing is certified by EMA. Its most recent recorded inspection, by US FDA, closed on 9 March 2018 as VAI. Customs aggregates show $18.9M of exports covering 273 molecules to 48 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Sahibzada Ajit Singh Nagar, India | 3007147039 |
| Molecule | Regulators | Docs |
|---|---|---|
| Atropine | US FDA | 2 |
| Carglumic Acid | US FDA | 2 |
| Dapagliflozin | US FDA | 2 |
| Dexketoprofen | US FDA | 2 |
| Diethylcarbamazine | US FDA | 2 |
| Homatropine | US FDA | 2 |
| Ipratropium | US FDA | 2 |
| Ketoprofen | US FDA | 2 |
| Nitisinone | US FDA | 2 |
| Papaverine | US FDA | 2 |
| Probenecid | US FDA | 2 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $4.6M | 26 |
| 2025 | Not reported | $18.9M | 48 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. SCL Lifesciences comes back tiered against every other supplier able to file there.
Start for free